Navigation Links
FDA Grants Permanent Hair Reduction Labeling for TRIA Laser Hair Removal System
Date:1/11/2010

DUBLIN, Calif., Jan. 11 /PRNewswire/ -- TRIA Beauty, the leader in light-based therapeutic beauty devices, today announced it received an additional over-the-counter (OTC) clearance from the United States Food and Drug Administration (FDA) for its flagship product, TRIA Laser Hair Removal System (LHRS). The TRIA laser is now FDA-cleared for permanent hair reduction, making it the first and only at-home hair removal device clinically proven to deliver permanent results.

"Our new FDA-clearance validates the superiority of TRIA laser over other at-home hair removal systems," said Kevin Appelbaum, CEO of TRIA Beauty. "This announcement is a testament to the advanced engineering and patented design intelligence that is the essence of TRIA Beauty."

According to a recent Dermatology Times survey, 82% of dermatologists prefer lasers to any other technology to achieve permanent hair removal. TRIA LHRS is the only at-home hair removal device on the market that utilizes a diode laser, the same technology used in professional laser hair removal systems and still considered the gold-standard treatment. In fact, the TRIA LHRS was developed by the scientists who invented the professional technology more than a decade ago.

The TRIA LHRS first received FDA clearance in February 2008 and has been recognized by industry authorities like Allure, WWD Beauty Biz, and Advertising Age for its game-changing innovation. In late 2009, TRIA Beauty launched a second generation TRIA LHRS that provides more power settings for improved comfort and performance. The second generation TRIA laser is sold at a 40% lower price than the original, making permanent hair reduction even more affordable to consumers.

This additional OTC clearance for TRIA LHRS comes just a day after TRIA Beauty received OTC clearance from the FDA for a proprietary hand-held blue light device designed for at-home use for the treatment of mild to moderate inflammatory acne. The new TRIA blue-light device is 10 times more powerful than other at-home blue light devices, continuing TRIA Beauty's heritage of innovation in beauty. It will be part of a dermatologist-validated system that will launch in Spring 2010.

The TRIA LHRS is priced at $595 and is available at TRIABeauty.com as well as on QVC, and at Bloomingdales, Neiman Marcus, Nordstrom, Bergdorf Goodman, STUDIO at Fred Segal, Bliss Spas and select physician offices.

About TRIA Beauty

TRIA Beauty, formerly known as SpectraGenics, brings home the very best in light-based skincare products. In 2008, TRIA Beauty revolutionized the hair removal industry with the first and only FDA-cleared laser hair removal system available for at home use, the TRIA Laser Hair Removal System. In 2010 TRIA Beauty will launch a clear skin system featuring FDA-cleared blue light technology that offers the most effective therapeutic dose of blue light for at-home use. FDA-cleared, clinically proven and easy to use, TRIA Beauty is committed to real science with beautiful results.

SOURCE TRIA Beauty

RELATED LINKS
http://www.TRIABeauty.com

'/>"/>

SOURCE TRIA Beauty
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. U.S. Labor Department Awards $10.1 Million for Safety and Health Training Grants
2. Sunesis Pharmaceuticals Reports New Option Grants Under NASDAQ Marketplace Rule 4350
3. American Cancer Society awards research grants to 109 investigators at 77 institutions nationwide
4. USAID Announces First Malaria Communities Program Grants
5. The Highmark Foundation Awards $580,000 in Highmark Healthy High 5 Grants to Four Non-Profit Organizations
6. KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants
7. FDA Grants Clearance to Langford IC Systems, Inc.
8. Dienst Custom Homes Grants Over 40 Wishes in Three Years
9. United Animal Nations Offers Financial Assistance Grants of up to $500 to Help Southern California Fire Victims Obtain Vet Care, Temporary Boarding for Pets
10. PA Health Department Awards Community Primary Care Challenge Grants
11. FDA Grants Kiadis Pharma Lead Product ATIR Orphan Drug Designation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... 23, 2017 , ... The Wound Certification Prep Course ... Holdings, LLC, today announced that RestorixHealth® has officially endorsed WCPC as ... interested in becoming Certified Wound Specialist Physicians (CWSP®). , This collaborative effort ...
(Date:3/23/2017)... ... 23, 2017 , ... Altec Products, Inc. , a ... their 2016 Microsoft Dynamics Partner of the Year at DocLink Evolution , ... recognizes The Resource Group for their outstanding relationship with Altec and their ability ...
(Date:3/23/2017)... ... March 23, 2017 , ... Natural Subsistence, ... aspects of people’s health and nutrition, announced its product Leyzene is now available ... Subsistence develops nutritional supplements that help people improve all aspects of their health ...
(Date:3/23/2017)... ... March 23, 2017 , ... The ... facing life-altering and fatal diseases in opposition to the President’s Fiscal Year ... eviscerate care, services, and hope for the most vulnerable among us. , The ...
(Date:3/23/2017)... Marina del Rey, CA (PRWEB) , ... March ... ... version of its customizable coding audit software solution, iCode Assurance, at HCCA’s 21st ... iCode Assurance optimizes and accelerates the coding audit process for all medical chart ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... 2017  A new genetic test has been ... individuals who carry HLA-B*15:02 and who ... potentially deadly side effect of certain medications used ... HLA-B*15:02 is strongly associated with life-threatening ... and toxic epidermal necrolysis in patients treated with ...
(Date:3/23/2017)... ALBANY, New York , March 23, 2017 ... devices market exhibits a consolidated vendor landscape with the ... the overall market in 2015. These companies are ... Industries, Inc., Hygia Health Services, Inc., and VANGUARD ... global reprocessed medical devices market is witnessing the ...
(Date:3/23/2017)... BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage ... it has acquired Agalimmune Ltd., a private UK-based company with ... $6 million upfront payment, of which $3 million is in ... may be made based on development and commercial milestones. ... Agalimmune,s lead ...
Breaking Medicine Technology: